| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2077363 | Cell Stem Cell | 2015 | 4 Pages |
Abstract
Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to stem cell patents, focusing on two recent cases, and discuss the future of stem cell patent disputes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Jacob S. Sherkow, Christopher Thomas Scott,